Regenesis Biomedical, Inc. News
Regenesis Biomedical Appoints Scientific Advisory Board Composed of Life Science and Electronics Experts
"This is another milestone in Regenesis' strategic plan to advance the science of wound care," said
The Regenesis Scientific Advisory Board brings together experts recognized in their fields:
* Metin Akay, Ph.D., Professor and Chairman of the Harrington Department of Bioengineering at Arizona State University, and founding chairman of the International IEEE Conference on Neural Engineering. * Hunt Dabney, President, Hunt Dabney & Associates. Leading expert in precision medical electronics and regulatory compliance mitigation. Holds 7 US patents with 7 patents pending. * Colin McCaig, Ph.D., Professor of Physiology and Head of School of Medical Sciences at the University of Aberdeen, Scotland. Researches role of endogenous direct current electrical fields in development and regeneration of tissues in cell culture, excised tissues and whole animals. * Dennis Orgill, M.D., Ph.D., Associate Professor at Harvard Medical School, Associate Chief of Plastic Surgery and Principal Investigator of the Wound Healing and Tissue Engineering Laboratory at Brigham and Women's Hospital.
About the Provant Wound Therapy System
Provant delivers cell proliferation induction(R) (CPI(R)) therapy based on Regenesis' proprietary pulsed radio frequency energy (PRFE) core technology platform. PRFE uses an optimized radiofrequency signal to stimulate dormant cells, causing them to replicate and to produce natural growth factors and other gene expression products, which facilitate reduction of the pain and edema associated with post-operative wound healing in soft tissues. We believe Provant is effective, economical, and easy-to-use.
About Regenesis Biomedical
Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Wound Therapy System. Our customers include health care facilities and providers that serve patients with wounds being treated by acute care hospitals, long- term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.
Contact: Regenesis Biomedical, Inc. Media: Scott Robey, VP Marketing robey@regenesisbiomedical.com Clinicians: Rick Isenberg, MD, VP Clinical Affairs isenberg@regenesisbiomedical.com Investors: Virginia Rybski, Acting President rybski@regenesisbiomedical.com http://www.regenesisbiomedical.com 480-970-4970
SOURCE Regenesis Biomedical, Inc.
Search Our News Using Google Search
Can't find what you want? Try using Google:
